CG
RVPH

Cutler Group’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Cutler Group’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-185
Closed -$3K – 4231
2023
Q3 		$3K Buy
+185
New +$17.2K ﹤0.01% 3145

Other funds holding RVPH

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $225M AUM 25.8% 1-Year Est. Return

Cutler Group's RVPH Position: Q1 2024 in Review

Cutler Group held its REVIVA PHARMA HLDGS INC (RVPH) position steady in Q1 2024 at 152 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1250.

Cutler Group first reported a position in RVPH in Q3 2023 and has held it in 3 quarters since. The position peaked at $15K in Q4 2023. 28 funds tracked by Wall St. Rank hold RVPH as of Q1 2024.

  • Cutler Group held 152 shares of REVIVA PHARMA HLDGS INC worth $11K as of Q1 2024.
  • Cutler Group left its REVIVA PHARMA HLDGS INC share count unchanged in Q1 2024.
  • REVIVA PHARMA HLDGS INC made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1250 holding.
  • Cutler Group first reported a position in REVIVA PHARMA HLDGS INC in Q3 2023 and has held it in 3 quarters since.
  • Cutler Group's REVIVA PHARMA HLDGS INC position peaked at $15K in Q4 2023.
  • 28 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.